Citation Impact
Citing Papers
Psychiatric Disorders Associated with Cushing??s Syndrome
2001
ECLAMC: The Latin-American Collaborative Study of Congenital Malformations
2004 Standout
Progressive hearing loss, and recurrent sudden sensorineural hearing loss associated with GJB2 mutations – phenotypic spectrum and frequencies of GJB2 mutations in Austria
2002
Molecular and Clinical Evidence for anARMC5Tumor Syndrome: Concurrent Inactivating Germline and Somatic Mutations Are Associated With Both Primary Macronodular Adrenal Hyperplasia and Meningioma
2014
Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells
2000
Cushing's Syndrome
1995
Variable Expression of the V1 Vasopressin Receptor Modulates the Phenotypic Response of Steroid-Secreting Adrenocortical Tumors1
1998
Cystic fibrosis
2016 Standout
Cushing’s Syndrome Secondary to Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia due to Activating Mutations ofGNAS1Gene
2003
Gastric Inhibitory Polypeptide–Dependent Cortisol Hypersecretion — A New Cause of Cushing's Syndrome
1992
CT and MR Imaging of the Adrenal Glands in ACTH-independent Cushing Syndrome
2004
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
2013
Cushing's syndrome
2015 Standout
Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study
2004
Abnormal Adrenal and Vascular Responses to Vasopressin Mediated by a V1-Vasopressin Receptor in a Patient with Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia, Cushing’s Syndrome, and Orthostatic Hypotension1
1997
Pharmacologic Management of Cushing Syndrome
2005
Using lanthanide-based resonance energy transfer for in vitro and in vivo studies of biological processes
2012
Adrenocorticotropin (ACTH)- and Non-ACTH-Mediated Regulation of the Adrenal Cortex: Neural and Immune Inputs
1999
Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex
2000 Standout
Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway
1999
Clinical and Genetic Heterogeneity, Overlap with Other Tumor Syndromes, and Atypical Glucocorticoid Hormone Secretion in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Compared with Other Adrenocortical Tumors
2009
The adolescent brain and age-related behavioral manifestations
2000 Standout
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Leuprolide Acetate Therapy in Luteinizing Hormone–Dependent Cushing's Syndrome
1999
The Diagnosis of Cushing's Syndrome
2000
CLINICAL AND BIOCHEMICAL EVALUATION OF CUSHING'S SYNDROME
1997
Biology of Incretins: GLP-1 and GIP
2007 Standout
Intraadrenal Corticotropin in Bilateral Macronodular Adrenal Hyperplasia
2013
A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis
2008
Aberrant Expression of Hormone Receptors in Adrenal Cushing's Syndrome
2004
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
The prevalence of cystic fibrosis in the European Union
2008
Cushing's syndrome variants secondary to aberrant hormone receptors
2004
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Is there a role for somatostatin and its analogs in Cushing's syndrome?
1996
Mutations of thePRKAR1AGene in Cushing’s Syndrome due to Sporadic Primary Pigmented Nodular Adrenocortical Disease
2002
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase
2013
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
2003
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
2013 Standout
Aberrant Interleukin-1 Receptors in a Cortisol-Secreting Adrenal Adenoma Causing Cushing's Syndrome
1998
Association of 24-Hour Cortisol Production Rates, Cortisol-Binding Globulin, and Plasma-Free Cortisol Levels with Body Composition, Leptin Levels, and Aging in Adult Men and Women
2004
The Aberrant Expression of the Gastric Inhibitory Polypeptide (GIP) Receptor in Adrenal Hyperplasia: Does Chronic Adrenocorticotropin Exposure Stimulate Up-Regulation of GIP Receptors in Cushing’s Disease?
2005
The Physiology of Glucagon-like Peptide 1
2007 Standout
ACTH-independent macronodular adrenal hyperplasia
2009
Ectopic Expression of the Gastric Inhibitory Polypeptide Receptor Gene Is a Sufficient Genetic Event to Induce Benign Adrenocortical Tumor in a Xenotransplantation Model
2005
The Ectopic Expression of the Gastric Inhibitory Polypeptide Receptor Is Frequent in Adrenocorticotropin-Independent Bilateral Macronodular Adrenal Hyperplasia, but Rare in Unilateral Tumors
2002
CFTR2: How will it help care?
2013
Cushing's syndrome
2006 Standout
Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases
2002
ClinVar: public archive of interpretations of clinically relevant variants
2015 Standout
Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction
2009
Population Screening in the Age of Genomic Medicine
2003
New developments in the medical treatment of Cushing's syndrome
2012
Propranolol Therapy for Ectopic β-Adrenergic Receptors in Adrenal Cushing's Syndrome
1997
Complete detection of mutations in cystic fibrosis patients of Native American origin
1994
Cushing’s Syndrome due to a Gastric Inhibitory Polypeptide-Dependent Adrenal Adenoma: Insights into Hormonal Control of Adrenocortical Tumorigenesis1
1998
Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome
2010
Adrenal Cushing's Syndrome Due to Bilateral Macronodular Adrenal Hyperplasia: Prediction of the Efficacy of .BETA.-blockade Therapy and Interest of Unilateral Adrenalectomy
2009
Adrenocortical Overexpression of Gastric Inhibitory Polypeptide Receptor Underlies Food-Dependent Cushing’s Syndrome1
1998
In Vivo and in Vitro Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing’s Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism
2005
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
Food-Dependent Cushing’s Syndrome: Characterization and Functional Role of Gastric Inhibitory Polypeptide Receptor in the Adrenals of Three Patients1
1998
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Paradoxical Response to Dexamethasone in the Diagnosis of Primary Pigmented Nodular Adrenocortical Disease
1999
Cushing’s Syndrome and Hypertension
1994
Glucocorticoid Action and the Clinical Features of Cushing’s Syndrome
1994
Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.
1993
Food-Dependent Cushing’s Syndrome: Possible Involvement of Leptin in Cortisol Hypersecretion*
1999
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
2016
Are Ectopic or Abnormal Membrane Hormone Receptors Frequently Present in Adrenal Cushing’s Syndrome?1
2000
The diversity of abnormal hormone receptors in adrenal Cushing's syndrome allows novel pharmacological therapies
2000
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Aberrant Membrane Hormone Receptors in Incidentally Discovered Bilateral Macronodular Adrenal Hyperplasia with Subclinical Cushing’s Syndrome
2001
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
ARMC5Mutations Are Common in Familial Bilateral Macronodular Adrenal Hyperplasia
2014
ARMC5Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia
2014
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing’s Syndrome*
2001
Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis
1998
Works of G Travert being referenced
Neonatal screening for cystic fibrosis: present and future
1999
A survey of newborn screening for cystic fibrosis in Europe
2006
Le programme national de depistage neonatal de la mucoviscidose mise en place et organisation
2003
Retrospective study of the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Guthrie cards from a large cohort of neonatal screening for cystic fibrosis
1994
Food-Dependent Cushing's Syndrome Mediated by Aberrant Adrenal Sensitivity to Gastric Inhibitory Polypeptide
1992